Want to see HK:1066 full AI Analyst Report?
Shandong Weigao Group Medical Polymer Co (1066) Ratios
Shandong Weigao Group Medical Polymer Co Ratios
HK:1066's free cash flow for Q2 2026 was $1.08B. For the 2026 fiscal year, HK:1066's free cash flow was increased by $0.00 and operating cash flow was $1.08B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.78 | 3.20 | 2.46 | 3.08 | 3.14 |
| Quick Ratio | 3.32 | 2.78 | 2.13 | 2.69 | 2.80 |
| Cash Ratio | 1.64 | 1.28 | 0.92 | 1.16 | 1.28 |
| Solvency Ratio | 0.25 | 0.31 | 0.30 | 0.37 | 0.32 |
| Operating Cash Flow Ratio | 0.47 | 0.46 | 0.37 | 0.37 | 0.59 |
| Short-Term Operating Cash Flow Coverage | 5.90 | 2.32 | 1.10 | 2.30 | 5.05 |
| Net Current Asset Value | $ 10.44B | $ 10.02B | $ 8.96B | $ 8.54B | $ 6.80B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.17 | 0.12 | 0.12 | 0.14 | 0.14 |
| Debt-to-Equity Ratio | 0.25 | 0.18 | 0.19 | 0.21 | 0.21 |
| Debt-to-Capital Ratio | 0.20 | 0.15 | 0.16 | 0.17 | 0.18 |
| Long-Term Debt-to-Capital Ratio | 0.15 | 0.11 | 0.06 | 0.14 | 0.15 |
| Financial Leverage Ratio | 1.50 | 1.46 | 1.50 | 1.53 | 1.58 |
| Debt Service Coverage Ratio | 3.69 | 1.89 | 1.15 | 3.42 | 4.50 |
| Interest Coverage Ratio | 6.82 | 9.56 | 7.48 | 15.28 | 20.57 |
| Debt to Market Cap | 0.23 | 0.21 | 0.13 | 0.09 | 0.11 |
| Interest Debt Per Share | 1.37 | 0.98 | 0.98 | 1.04 | 0.95 |
| Net Debt to EBITDA | -1.06 | -1.14 | -0.79 | -0.54 | -0.66 |
| Profitability Margins | |||||
| Gross Profit Margin | 47.26% | 50.28% | 50.21% | 53.64% | 55.91% |
| EBIT Margin | 13.79% | 17.37% | 19.97% | 26.27% | 22.95% |
| EBITDA Margin | 21.16% | 24.01% | 26.86% | 32.16% | 28.55% |
| Operating Profit Margin | 12.69% | 18.23% | 15.44% | 21.47% | 21.96% |
| Pretax Profit Margin | 15.17% | 19.51% | 17.91% | 24.86% | 21.88% |
| Net Profit Margin | 12.04% | 15.79% | 15.13% | 20.30% | 17.31% |
| Continuous Operations Profit Margin | 12.78% | 16.53% | 15.58% | 21.66% | 18.69% |
| Net Income Per EBT | 79.36% | 80.93% | 84.50% | 81.64% | 79.08% |
| EBT Per EBIT | 119.58% | 107.02% | 115.99% | 115.77% | 99.66% |
| Return on Assets (ROA) | 4.47% | 5.95% | 5.95% | 8.33% | 7.49% |
| Return on Equity (ROE) | 6.68% | 8.70% | 8.92% | 12.76% | 11.81% |
| Return on Capital Employed (ROCE) | 5.55% | 8.32% | 7.83% | 10.73% | 11.46% |
| Return on Invested Capital (ROIC) | 4.60% | 6.75% | 6.20% | 8.96% | 9.50% |
| Return on Tangible Assets | 5.15% | 6.98% | 7.00% | 9.93% | 9.02% |
| Earnings Yield | 7.88% | 10.59% | 6.57% | 5.42% | 6.38% |
| Efficiency Ratios | |||||
| Receivables Turnover | 1.62 | 1.76 | 2.22 | 2.37 | 2.53 |
| Payables Turnover | 5.79 | 1.52 | 1.52 | 3.61 | 3.46 |
| Inventory Turnover | 2.81 | 2.57 | 2.64 | 2.81 | 3.30 |
| Fixed Asset Turnover | 1.78 | 1.85 | 1.89 | 1.86 | 1.97 |
| Asset Turnover | 0.37 | 0.38 | 0.39 | 0.41 | 0.43 |
| Working Capital Turnover Ratio | 0.94 | 1.07 | 1.13 | 1.16 | 1.26 |
| Cash Conversion Cycle | 292.86 | 108.88 | 63.34 | 182.59 | 149.20 |
| Days of Sales Outstanding | 225.86 | 207.93 | 164.44 | 153.71 | 144.07 |
| Days of Inventory Outstanding | 130.05 | 141.84 | 138.29 | 129.90 | 110.56 |
| Days of Payables Outstanding | 63.05 | 240.89 | 239.39 | 101.02 | 105.43 |
| Operating Cycle | 355.91 | 349.77 | 302.72 | 283.61 | 254.63 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.56 | 0.61 | 0.62 | 0.49 | 0.67 |
| Free Cash Flow Per Share | 0.38 | 0.48 | 0.46 | 0.24 | 0.43 |
| Dividend Paid and CapEx Coverage Ratio | 1.37 | 1.90 | 1.97 | 1.19 | 1.71 |
| Capital Expenditure Coverage Ratio | 3.06 | 4.68 | 4.08 | 1.98 | 2.72 |
| Operating Cash Flow Coverage Ratio | 0.43 | 0.67 | 0.67 | 0.49 | 0.73 |
| Operating Cash Flow to Sales Ratio | 0.19 | 0.21 | 0.21 | 0.16 | 0.23 |
| Free Cash Flow Yield | 8.40% | 11.23% | 6.94% | 2.15% | 5.38% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 12.88 | 9.45 | 15.22 | 18.45 | 15.67 |
| Price-to-Sales (P/S) Ratio | 1.53 | 1.49 | 2.30 | 3.74 | 2.71 |
| Price-to-Book (P/B) Ratio | 0.85 | 0.82 | 1.36 | 2.35 | 1.85 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 11.91 | 8.91 | 14.42 | 46.44 | 18.59 |
| Price-to-Operating Cash Flow Ratio | 8.02 | 7.00 | 10.89 | 23.03 | 11.75 |
| Price-to-Earnings Growth (PEG) Ratio | -0.54 | 2.08 | -0.55 | 0.94 | 1.44 |
| Enterprise Value Multiple | 6.16 | 5.07 | 7.78 | 11.10 | 8.83 |
| Enterprise Value | 17.46B | 15.94B | 27.65B | 48.63B | 33.17B |
| EV to EBITDA | 6.16 | 5.07 | 7.78 | 11.10 | 8.83 |
| EV to Sales | 1.30 | 1.22 | 2.09 | 3.57 | 2.52 |
| EV to Free Cash Flow | 10.17 | 7.27 | 13.08 | 44.28 | 17.29 |
| EV to Operating Cash Flow | 6.85 | 5.71 | 9.88 | 21.96 | 10.93 |
| Tangible Book Value Per Share | 4.65 | 4.45 | 4.16 | 4.01 | 3.50 |
| Shareholders’ Equity Per Share | 5.31 | 5.23 | 4.93 | 4.81 | 4.28 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.16 | 0.15 | 0.13 | 0.13 | 0.15 |
| Revenue Per Share | 2.95 | 2.88 | 2.91 | 3.02 | 2.92 |
| Net Income Per Share | 0.36 | 0.46 | 0.44 | 0.61 | 0.51 |
| Tax Burden | 0.79 | 0.81 | 0.84 | 0.82 | 0.79 |
| Interest Burden | 1.10 | 1.12 | 0.90 | 0.95 | 0.95 |
| Research & Development to Revenue | 0.06 | 0.05 | 0.06 | 0.04 | 0.04 |
| SG&A to Revenue | 0.29 | 0.28 | 0.09 | 0.08 | 0.08 |
| Stock-Based Compensation to Revenue | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 |
| Income Quality | 1.26 | 1.09 | 1.18 | 0.67 | 1.07 |
Currency in CNY
